Recruiting Clinical Trials

Pemetrexed and Erlotinib for Metastatic Colorectal Cancer

By April 24, 2017 No Comments


Metastatic Colorectal Cancer

Estimated Enrollment: 50

Age Group: 19 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment

Study ID Numbers: 4-2015-0617

Study First Received: March 9, 2016

Last Updated: July 12, 2016

Estimated Primary Completion Date: July 2017


Primary Outcome Measures:

Overall response rate|Progression-free survival|Overall survival|Disease control rate|Number of participants with treatment-related adverse events as assessed by CTCAE v4.0

Sponsors and Collaborators:

Yonsei University

Website Link:

Leave a Reply

Call Now ButtonCall Now